Please login to the form below

Not currently logged in

Excellence in Communications via Meetings

Sponsored by

Back to results


OptiMiSe: An Innovative Meetings-based Learning Journey for Clinical Behaviour Change among Multiple Sclerosis Specialist Nurses

by Lucid Group for Sanofi Genzyme

Summary of work

OptiMiSe: An Innovative Meetings-based Learning Journey for Clinical Behaviour Change among Multiple Sclerosis Specialist Nurses

The varied aetiology of multiple sclerosis (MS), and individual responses to treatment, mean that optimal management demands a patient-centric approach. OptiMiSe for MS specialist nurses (MSSNs) is an innovative expert-led learning journey for clinical behaviour change, designed specifically to support MS nurses in delivering this patient-centric management to all patients. A thorough understanding of the barriers MSSNs face in providing optimal patient care, gained through a survey evaluating current clinical practice, has informed the OptiMiSe programme since its launch in 2016. Through annual standalone meetings, workshops and additional tools to support the learning journey, designed using proven behaviour-change tactics tailored to meet the identified clinical practice needs, we have been able to effect a change in MSSN behaviour to improve patient outcomes. For example, there has been a 35% increase in the proportion of MSSNs for whom the majority of their patients are receiving multidisciplinary team assessments, an aspect of care that has been shown to improve activity levels in MS patients. We are continuing to work with a Steering Committee of MSSNs to expand and tailor content for 2018 and beyond, ensuring that it remains focused on addressing real clinical practice needs and, ultimately, improving care for MS patients.

Judges' comments

This articulate entry displayed impressive outcomes and metrics. It not only linked into the needs of the patients, but for the result to reach over half the population in the UK was truly remarkable. This is everything you could want from a meeting.

Highly commended

Act on PAH – Improve Patient Outcomes with Early Diagnosis - by NexGen Healthcare Communications for Actelion Pharmaceuticals UK Ltd


ART Perspectives - by emotive. for ViiV Healthcare

Developing the ‘Women’s Health Hub’ Model - by Incisive Health for Bayer Ltd

Comparing Cancer Outcomes to Drive Improvements in Patient Care - by Incisive Health for The Association of the British Pharmaceutical Industry

Category Sponsors

Debbie Tuesley - Communiqué Awards Director

Key dates

Entry deadline 11 March 2021
Extended entry deadline 18 March 2021
(additional fee applies)
Judging days May 2021
Awards Ceremony 1st September 2021

Contact information:

For sponsorship opportunities:
Sales Team
Tel: +44 (0)1372 414200

General event enquiries:
Debbie Tuesley
Tel: +44 (0)1372 414243